Literature DB >> 23596552

Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers.

Dimitra Dimitropoulou1, Marina Karakantza, Georgios L Theodorou, Lydia Leonidou, Stelios F Assimakopoulos, Athanasia Mouzaki, Charalambos A Gogos.   

Abstract

An insufficient cellular immune response seems to be critical for the immunopathogenesis of chronic hepatitis B virus infection. We have previously demonstrated no differences of T-lymphocyte subsets in blood between inactive hepatitis B s antigen (HBsAg) carriers and patients with HBeAg-negative chronic active hepatitis B. This study investigated the peripheral blood cytokine profile in patients with HBeAg-negative chronic active hepatitis B infection (Group A, n = 21) and inactive HBsAg carriers (Group B, n = 13). Serum cytokines [interferon (IFN)-γ, tumor necrosis factor-α, interleukin (IL)-1b, IL-4, IL-12, IL-10, IL-2, IL-5, IL-8] were analyzed by using flow cytometry. Patients with chronic active disease presented with significantly decreased levels of IFN-γ and IL-10 compared to inactive carriers (P = 0.048 and P = 0.008, respectively). In HBeAg-negative chronic active hepatitis B patients, a significant negative correlation of IFN-γ levels with serum hepatitis B viral load was noted (P = 0.021). In conclusion, patients with HBeAg-negative chronic active hepatitis B and HBsAg inactive carriers display a different cytokine profile. Decreased Th1 response observed in patients with chronic active hepatitis B could be implicated in the persistence of virus replication and ongoing progression of liver disease.

Entities:  

Keywords:  Cytokines; Flow cytometry; Hepatitis B; Immunoreactive fibronectin-γ

Year:  2013        PMID: 23596552      PMCID: PMC3627460          DOI: 10.4291/wjgp.v4.i1.24

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  11 in total

1.  Viral clearance without destruction of infected cells during acute HBV infection.

Authors:  L G Guidotti; R Rochford; J Chung; M Shapiro; R Purcell; F V Chisari
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

Authors:  C Ferrari; A Penna; A Bertoletti; A Valli; A D Antoni; T Giuberti; A Cavalli; M A Petit; F Fiaccadori
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

Review 3.  Pathogenesis of hepatitis B virus infection.

Authors:  Thomas F Baumert; Robert Thimme; Fritz von Weizsäcker
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 4.  The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection.

Authors:  Luca G Guidotti
Journal:  Vaccine       Date:  2002-12-19       Impact factor: 3.641

Review 5.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

Review 6.  The immune response during hepatitis B virus infection.

Authors:  Antonio Bertoletti; Adam J Gehring
Journal:  J Gen Virol       Date:  2006-06       Impact factor: 3.891

Review 7.  The natural history of chronic hepatitis B.

Authors:  C-L Lai; M-F Yuen
Journal:  J Viral Hepat       Date:  2007-11       Impact factor: 3.728

8.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.

Authors:  L G Guidotti; K Ando; M V Hobbs; T Ishikawa; L Runkel; R D Schreiber; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Role of hepatitis B virus specific cytotoxic T cells in liver damage and viral control.

Authors:  A Bertoletti; M Maini; Roger Williams
Journal:  Antiviral Res       Date:  2003-10       Impact factor: 5.970

Review 10.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

View more
  7 in total

1.  Lymphocyte CD64 increased in patients with chronic HBV infection.

Authors:  Hao Feng; Jie Yin; Ya-Ping Han; Xiao-Ying Zhou; Guo-Xin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 2.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

3.  Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis.

Authors:  M Özgüler; H H Akbulut; A Akbulut
Journal:  West Indian Med J       Date:  2015-01-27       Impact factor: 0.171

4.  Regulatory T cells and IL-17(+) T helper cells enhanced in patients with chronic hepatitis B virus infection.

Authors:  Hao Feng; Jie Yin; Ya-Ping Han; Xiao-Ying Zhou; Su Chen; Li Yang; Jin-Rui Yan; Guo-Xin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

5.  Controversial issues regarding the roles of IL-10 and IFN-γ in active/inactive chronic hepatitis B.

Authors:  Hossein Khorramdelazad; Gholamhossein Hassanshahi; Mohammad Kazemi Arababadi
Journal:  World J Gastrointest Pathophysiol       Date:  2014-05-15

Review 6.  TLR3 plays significant roles against hepatitis B virus.

Authors:  Masoud Karimi-Googheri; Mohammad Kazemi Arababadi
Journal:  Mol Biol Rep       Date:  2014-01-30       Impact factor: 2.316

7.  Evaluation of hepatitis B surface antibody and specific gamma interferon response in health care workers after vaccination.

Authors:  Mohammad Hosein Sarmast Shooshtari; Manoochehr Makvandi; Mojtaba Rasti; Niloofar Neisi; Nasrin Rastegarvand; Amir Pouremamali; Mehrdad Sadeghi Haj; Fardin Ghaedi
Journal:  Jundishapur J Microbiol       Date:  2014-12-06       Impact factor: 0.747

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.